Dear Association Executives - Below and at the link below, please find a model law that the White House/ONDCP helped to develop to increase access to Naloxone.
https://legislativeanalysis.org/model-expanded-access-to-emergency-opioid-antagonists-act/
APPA's Model Expanded Access to Emergency Opioid Antagonists Act provides state officials with the means to increase the ability of their citizens to access and use life-saving emergency opioid antagonists. The Centers for Disease Control and Prevention estimates that over 934,000 Americans died from a fatal overdose involving an opioid between 1999 and 2020. Opioid antagonists, such as naloxone, can be used during emergencies to reverse opioid overdoses and are effective in preventing fatal drug overdoses. This Act: (1) enables all citizens to access emergency opioid antagonists; (2) encourages citizens to obtain emergency opioid antagonists; (3) grants immunity to individuals who administer opioid antagonists; (4) requires physicians to co-prescribe an emergency opioid antagonist when prescribing an opioid to someone; (5) ensures that health insurance covers emergency opioid antagonists, like naloxone; (6) prohibits discriminatory life and health insurance practices related to the possession of emergency opioid antagonists; (7) provides increased access to opioid antagonists in educational institutions and correctional settings; (8) establishes a pilot program to increase bystander access to emergency opioid antagonists; and (9) promotes initiatives that educate citizens on the life-saving potential of emergency opioid antagonists.
---------------------------------------
Chuck Ingoglia
President & CEO
National Council for Mental Wellbeing
Direct: (202) 684-3749
------------------------------
Neal Comstock
Director of Membership
National Council
NealC@TheNationalCouncil.org202 748-8793
------------------------------
Original Message:
Sent: 10-24-2022 17:49
From: Annette Dubas
Subject: Access to NarCan(Naloxone
I am looking for state policies related to access to Naloxone. Since this is still a controlled drug, with access only through prescription, our providers aren't able to keep a supply on hand. Just looking for policies or regulations that make access easier for providers and consumers.
------------------------------
Annette Dubas
Executive Director
Nebraska Association of Behavioral Health Organizations
Fullerton NE
308-550-0614
------------------------------